Detalles de la búsqueda
1.
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.
N Engl J Med
; 388(25): 2315-2325, 2023 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37224232
2.
Improved implicit self-esteem is associated with extended antidepressant effects following a novel synergistic intervention.
Mol Psychiatry
; 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38755245
3.
Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial.
Mol Psychiatry
; 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38454079
4.
Characterization of Extended-Release Lorazepam: Pharmacokinetic Results Across Phase 1 Clinical Studies.
J Clin Psychopharmacol
; 43(4): 350-360, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37335199
5.
International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators.
Mol Psychiatry
; 27(12): 5096-5112, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36071111
6.
Nighttime Sleep Quality and Daytime Sleepiness Predicts Suicide Risk in Adults Admitted to an Inpatient Psychiatric Hospital.
Behav Sleep Med
; 21(2): 129-141, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-35296204
7.
A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine.
Int J Neuropsychopharmacol
; 25(10): 827-838, 2022 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35994774
8.
Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progress.
Ann Clin Psychiatry
; 34(1): 33-43, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35166663
9.
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. Reply.
N Engl J Med
; 389(10): 961-962, 2023 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37672705
10.
Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression.
Int J Neuropsychopharmacol
; 24(5): 383-391, 2021 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33249434
11.
Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
Mol Psychiatry
; 25(7): 1604, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30617276
12.
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
Mol Psychiatry
; 25(7): 1592-1603, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30283029
13.
Neurophysiological and clinical effects of the NMDA receptor antagonist lanicemine (BHV-5500) in PTSD: A randomized, double-blind, placebo-controlled trial.
Depress Anxiety
; 38(11): 1108-1119, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34254405
14.
Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder.
J Clin Psychopharmacol
; 40(3): 287-292, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32332464
15.
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches.
Mol Psychiatry
; 24(4): 576-587, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29955162
16.
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression.
Depress Anxiety
; 36(3): 235-243, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30597688
17.
Placebo Effects Across Self-Report, Clinician Rating, and Objective Performance Tasks Among Women With Post-Traumatic Stress Disorder: Investigation of Placebo Response in a Pharmacological Treatment Study of Post-Traumatic Stress Disorder.
J Clin Psychopharmacol
; 38(3): 200-206, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29505471
18.
Heightened early-attentional stimulus orienting and impulsive action in men with antisocial personality disorder.
Eur Arch Psychiatry Clin Neurosci
; 267(7): 697-707, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27662886
19.
Assessment of the Efficacy and Safety of BMS-820836 in Patients With Treatment-Resistant Major Depression: Results From 2 Randomized, Double-Blind Studies.
J Clin Psychopharmacol
; 35(4): 454-9, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25961781
20.
A Novel Anxiety and Affective Spectrum Disorder of Mind and Body-The ALPIM (Anxiety-Laxity-Pain-Immune-Mood) Syndrome: A Preliminary Report.
J Neuropsychiatry Clin Neurosci
; 27(2): 93-103, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25923849